# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
New technology has potential to accelerate timelines for therapeutic research and drug developmentTelesis Bio Inc. (OTC:TBIO), ...
Telesis Bio shares are moving higher on Thursday after the company announced a partnership with Beckman Coulter Life Sciences.